Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Clustered regulatory interspaced short palindromic repeats (CRISPR) has changed
biomedical research and provided entirely new models to analyze every aspect of …
biomedical research and provided entirely new models to analyze every aspect of …
Molecular regulators of HOXA9 in acute myeloid leukemia
Dysregulation of the oncogenic transcription factor HOXA9 is a prominent feature for most
aggressive acute myeloid leukemia cases and a strong indicator of poor prognosis in …
aggressive acute myeloid leukemia cases and a strong indicator of poor prognosis in …
Circular RNAs—New Kids on the Block in Cancer Pathophysiology and Management
A Szczepaniak, A Bronisz, J Godlewski - Cells, 2023 - mdpi.com
The ever-increasing number of cancer cases and persistently high mortality underlines the
urgent need to acquire new perspectives for developing innovative therapeutic approaches …
urgent need to acquire new perspectives for developing innovative therapeutic approaches …
The long and short: non-coding RNAs in the mammalian inner ear
T Koffler-Brill, Y Noy, KB Avraham - Hearing research, 2023 - Elsevier
Non-coding RNAs (ncRNAs) play a critical role in the entire body, and their mis-regulation is
often associated with disease. In parallel with the advances in high-throughput sequencing …
often associated with disease. In parallel with the advances in high-throughput sequencing …
Circular RNA expression signatures provide promising diagnostic and therapeutic biomarkers for chronic lymphocytic leukemia
Simple Summary This study aimed to evaluate the potential of circular RNA (circRNA)
expression profiles for the early detection of chronic lymphocytic leukemia (CLL) using …
expression profiles for the early detection of chronic lymphocytic leukemia (CLL) using …
Circular RNA circ_0000741/miR-379-5p/TRIM14 signaling axis promotes HDAC inhibitor (SAHA) tolerance in glioblastoma
L Meng, Y Wang, Q Tu, Y Zhu, X Dai, J Yang - Metabolic Brain Disease, 2023 - Springer
Background Histone deacetylase (HDAC) inhibitor-based therapeutic drug tolerance is a
major obstacle to glioblastoma (GBM) treatment. Meanwhile, non-coding RNAs have been …
major obstacle to glioblastoma (GBM) treatment. Meanwhile, non-coding RNAs have been …
HGNNLDA: predicting lncRNA-drug sensitivity associations via a dual channel hypergraph neural network
Drug sensitivity is critical for enabling personalized treatment. Many studies have shown that
long non-coding RNAs (lncRNAs) are closely related to drug sensitivity because lncRNAs …
long non-coding RNAs (lncRNAs) are closely related to drug sensitivity because lncRNAs …
[HTML][HTML] Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
T Zhang, D Liao, Y Hu - Translational Cancer Research, 2023 - ncbi.nlm.nih.gov
Background Acute myeloid leukemia (AML) is a highly heterogeneous cluster of
hematologic malignancies. Leukemic stem cells (LSCs) are one of the culprits for the …
hematologic malignancies. Leukemic stem cells (LSCs) are one of the culprits for the …
Upregulation of lncRNA PTOV1‐AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR‐505
X Chi, Z Chen, Y Chen, H Hong… - Journal of Biochemical …, 2023 - Wiley Online Library
Increasing evidence has displayed the vital influence of lncRNA in tumorigenesis and
chemoresistance of cancer treatment. This study investigated the function of lncRNA PTOV1 …
chemoresistance of cancer treatment. This study investigated the function of lncRNA PTOV1 …
The expression and function of long noncoding RNAs in hepatocellular carcinoma
J Du, Y Su, J Gao, Y Tai - Cancer Innovation, 2023 - Wiley Online Library
With the deepening of the genome project study, attention on noncoding RNAs is increasing.
Long noncoding RNAs (lncRNAs) have become a new research hotspot. A growing number …
Long noncoding RNAs (lncRNAs) have become a new research hotspot. A growing number …